id,name,unit,description,createdAt,updatedAt,code,coverage,timespan,datasetId,sourceId,shortUnit,display,columnOrder,originalMetadata,grapherConfigAdmin,shortName,catalogPath,dimensions,schemaVersion,processingLevel,processingLog,titlePublic,titleVariant,attributionShort,attribution,descriptionShort,descriptionFromProducer,descriptionKey,descriptionProcessing,licenses,license,grapherConfigETL,type,sort,dataChecksum,metadataChecksum
686700,Hospital pharmaceutical market (Market: % share of generics (volume)),%,,2023-05-04 14:12:49,2024-07-08 16:19:12,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,hospital_pharmaceutical_market__market__pct_share_of_generics__volume,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#hospital_pharmaceutical_market__market__pct_share_of_generics__volume,,1,,,,,,,,,[],,,,,float,[],a0b3f655137fc0d872e5afc190e32716,e2439a3765913e197db28c45af9cce26
686699,Community pharmacy market (Market: % share of generics (volume)),%,,2023-05-04 14:12:49,2024-07-08 16:19:12,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,community_pharmacy_market__market__pct_share_of_generics__volume,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#community_pharmacy_market__market__pct_share_of_generics__volume,,1,,,,,,,,,[],,,,,float,[],49800617c3aa926840851e7045025277,e01cb9067029d3c5c747d7f12ee22247
686698,Hospital pharmaceutical market (Market: % share of generics (value)),%,,2023-05-04 14:12:49,2024-07-08 16:19:12,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,hospital_pharmaceutical_market__market__pct_share_of_generics__value,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#hospital_pharmaceutical_market__market__pct_share_of_generics__value,,1,,,,,,,,,[],,,,,float,[],e4a5c4d8b3ec219563851cb79736ad7e,2f12ae0749d468267fbc22bdeac51a2a
686697,Community pharmacy market (Market: % share of generics (value)),%,,2023-05-04 14:12:49,2024-07-08 16:19:12,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,community_pharmacy_market__market__pct_share_of_generics__value,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#community_pharmacy_market__market__pct_share_of_generics__value,,1,,,,,,,,,[],,,,,float,[],6ea3e7ae0428935648c7336328d6f61d,96f7c6e5042e88fe348eed5f5b21df96
686696,Third-party-payer market (Market: % share of generics (volume)),%,,2023-05-04 14:12:49,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,third_party_payer_market__market__pct_share_of_generics__volume,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#third_party_payer_market__market__pct_share_of_generics__volume,,1,,,,,,,,,[],,,,,float,[],06ce3f326adda9cc822c737d1b2aef52,53fd4fbd7d8d19ad55ae2d3983e6d296
686695,Third-party-payer market (Market: % share of generics (value)),%,,2023-05-04 14:12:49,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,third_party_payer_market__market__pct_share_of_generics__value,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#third_party_payer_market__market__pct_share_of_generics__value,,1,,,,,,,,,[],,,,,float,[],5f66f23d8e5021adfa9d3cf0573667fb,ffe85b5c1bfdfa75aaf27e54bbb13f7c
686694,Total pharmaceutical market (Market: % share of generics (volume)),%,,2023-05-04 14:12:49,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,total_pharmaceutical_market__market__pct_share_of_generics__volume,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#total_pharmaceutical_market__market__pct_share_of_generics__volume,,1,,,,,,,,,[],,,,,float,[],5e4a057be2665f592df4b996b0f594c4,465eae1cc2505102dc47d5a22d51f8bd
686693,Total pharmaceutical market (Market: % share of generics (value)),%,,2023-05-04 14:12:49,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,total_pharmaceutical_market__market__pct_share_of_generics__value,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#total_pharmaceutical_market__market__pct_share_of_generics__value,,1,,,,,,,,,[],,,,,float,[],6b426ab96d8b0b37fc5cebc70d639563,bf5fa3ee954579583154ed5b05bf0997
686692,Products not elsewhere classified (Sales: % of total sales),%,,2023-05-04 14:12:49,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,products_not_elsewhere_classified__sales__pct_of_total_sales,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#products_not_elsewhere_classified__sales__pct_of_total_sales,,1,,,,,,,,,[],,,,,float,[],bb048774b2584f6584abec5a3b608eda,8275e91225b6e76ed34aa2d3648ddaca
686691,Products not elsewhere classified (Sales: US$ (exchange rate) per capita),US$ per capita,,2023-05-04 14:12:49,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,products_not_elsewhere_classified__sales__usd__exchange_rate__per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#products_not_elsewhere_classified__sales__usd__exchange_rate__per_capita,,1,,,,,,,,,[],,,,,float,[],a20147fe6cf4523f5f3f780eefd1f90f,845944ee942da31c76bc7ebcaa228417
686690,"Products not elsewhere classified (Sales: Million US$, purchasing power parity)",million US$,,2023-05-04 14:12:49,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,products_not_elsewhere_classified__sales__million_usd__purchasing_power_parity,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#products_not_elsewhere_classified__sales__million_usd__purchasing_power_parity,,1,,,,,,,,,[],,,,,float,[],596db51d242fd4db03c4175217c26663,9c36bd9aba3c80501da6fa28576834dc
686689,Products not elsewhere classified (Sales: US$ (purchasing power parity per capita),US$ per capita,,2023-05-04 14:12:49,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,products_not_elsewhere_classified__sales__usd__purchasing_power_parity_per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#products_not_elsewhere_classified__sales__usd__purchasing_power_parity_per_capita,,1,,,,,,,,,[],,,,,float,[],33407b5c1e978cfb09e9e25f4c181143,d7699d01e938809f4dfd601bd9d0dec1
686688,Products not elsewhere classified (Sales: Million US$ at exchange rate),million US$,,2023-05-04 14:12:49,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,products_not_elsewhere_classified__sales__million_usd_at_exchange_rate,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#products_not_elsewhere_classified__sales__million_usd_at_exchange_rate,,1,,,,,,,,,[],,,,,float,[],c4bdd5be1fdd386a81844a188f2b1e5c,6cfd6d77b928030a0f41af2e872026b5
686687,Products not elsewhere classified (Sales: Million of national currency units),million of national currency units,,2023-05-04 14:12:49,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""million of national currency units""}",0,,,products_not_elsewhere_classified__sales__million_of_national_currency_units,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#products_not_elsewhere_classified__sales__million_of_national_currency_units,,1,,,,,,,,,[],,,,,float,[],61a635abaa9af2facc432e2ad9531c15,0e3ffcaa39a587b7b7124247a934a92c
686686,R03-Drugs for obstructive airway diseases (Sales: % of total sales),%,,2023-05-04 14:12:49,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,r03_drugs_for_obstructive_airway_diseases__sales__pct_of_total_sales,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r03_drugs_for_obstructive_airway_diseases__sales__pct_of_total_sales,,1,,,,,,,,,[],,,,,float,[],a6eccf6ed8ac180c0809182d30cb7685,c0fc33db417f695854c59fe29482b7af
686685,R03-Drugs for obstructive airway diseases (Sales: US$ (purchasing power parity per capita),US$ per capita,,2023-05-04 14:12:49,2024-07-08 16:19:12,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,r03_drugs_for_obstructive_airway_diseases__sales__usd__purchasing_power_parity_per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r03_drugs_for_obstructive_airway_diseases__sales__usd__purchasing_power_parity_per_capita,,1,,,,,,,,,[],,,,,float,[],0ed6fa58ef347eab5d665f99482a86b1,3f08b8cdd3d495f3bf6dbc0b608983aa
686684,R03-Drugs for obstructive airway diseases (Sales: US$ (exchange rate) per capita),US$ per capita,,2023-05-04 14:12:49,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,r03_drugs_for_obstructive_airway_diseases__sales__usd__exchange_rate__per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r03_drugs_for_obstructive_airway_diseases__sales__usd__exchange_rate__per_capita,,1,,,,,,,,,[],,,,,float,[],5325156ade2222e33686525f3a9a6044,e8c35d47cd4b9760c116e37635bfe191
686683,"R03-Drugs for obstructive airway diseases (Sales: Million US$, purchasing power parity)",million US$,,2023-05-04 14:12:49,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,r03_drugs_for_obstructive_airway_diseases__sales__million_usd__purchasing_power_parity,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r03_drugs_for_obstructive_airway_diseases__sales__million_usd__purchasing_power_parity,,1,,,,,,,,,[],,,,,float,[],0fbb8de83efa6a4b0e8eef6ad7ae0964,e27f494e18c5332ca801596f957cb6ce
686682,R03-Drugs for obstructive airway diseases (Sales: Million US$ at exchange rate),million US$,,2023-05-04 14:12:48,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,r03_drugs_for_obstructive_airway_diseases__sales__million_usd_at_exchange_rate,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r03_drugs_for_obstructive_airway_diseases__sales__million_usd_at_exchange_rate,,1,,,,,,,,,[],,,,,float,[],9f5fe4c98b0968632c17fb907d6328d4,b523894c61fbbaa4061519d26549d945
686681,R03-Drugs for obstructive airway diseases (Sales: Million of national currency units),million of national currency units,,2023-05-04 14:12:48,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""million of national currency units""}",0,,,r03_drugs_for_obstructive_airway_diseases__sales__million_of_national_currency_units,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r03_drugs_for_obstructive_airway_diseases__sales__million_of_national_currency_units,,1,,,,,,,,,[],,,,,float,[],a6c923185e4dda91d43d2b74f86c47e8,7fba621af5b15737787b4b1fb9c3e638
686680,R-Respiratory system (Sales: % of total sales),%,,2023-05-04 14:12:48,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,r_respiratory_system__sales__pct_of_total_sales,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r_respiratory_system__sales__pct_of_total_sales,,1,,,,,,,,,[],,,,,float,[],605b05811edb1945099a4b2ed62b0c1b,61d5cca32f7834d0d8b1e8d9e1ea8195
686679,R-Respiratory system (Sales: US$ (exchange rate) per capita),US$ per capita,,2023-05-04 14:12:48,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,r_respiratory_system__sales__usd__exchange_rate__per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r_respiratory_system__sales__usd__exchange_rate__per_capita,,1,,,,,,,,,[],,,,,float,[],a5a74cf80fb5a8a55cf59c132559aeb1,cd71cd09418b8919dae04ed515205025
686678,R-Respiratory system (Sales: US$ (purchasing power parity per capita),US$ per capita,,2023-05-04 14:12:48,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,r_respiratory_system__sales__usd__purchasing_power_parity_per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r_respiratory_system__sales__usd__purchasing_power_parity_per_capita,,1,,,,,,,,,[],,,,,float,[],37bf23b9521f47d8c5f10f1c65878386,0c48f4f0e05f526515b109e1280d2f9d
686677,"R-Respiratory system (Sales: Million US$, purchasing power parity)",million US$,,2023-05-04 14:12:48,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,r_respiratory_system__sales__million_usd__purchasing_power_parity,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r_respiratory_system__sales__million_usd__purchasing_power_parity,,1,,,,,,,,,[],,,,,float,[],725e1b95c9e8cb3a9b4d127ab64aafe4,20f4a113655246457db0f074ddc35ea1
686676,R-Respiratory system (Sales: Million US$ at exchange rate),million US$,,2023-05-04 14:12:48,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,r_respiratory_system__sales__million_usd_at_exchange_rate,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r_respiratory_system__sales__million_usd_at_exchange_rate,,1,,,,,,,,,[],,,,,float,[],cc224b55de8461f621da7106a6d06201,fde1d8e70b271b27e693d05934171c9c
686675,R-Respiratory system (Sales: Million of national currency units),million of national currency units,,2023-05-04 14:12:48,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""million of national currency units""}",0,,,r_respiratory_system__sales__million_of_national_currency_units,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r_respiratory_system__sales__million_of_national_currency_units,,1,,,,,,,,,[],,,,,float,[],f565ab11d9ac6c396b950e5d6d123db4,58d6e7c82ddb30cb4328d790f46f3a4a
686674,N06A-Antidepressants (Sales: % of total sales),%,,2023-05-04 14:12:48,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,n06a_antidepressants__sales__pct_of_total_sales,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n06a_antidepressants__sales__pct_of_total_sales,,1,,,,,,,,,[],,,,,float,[],1d07b2b7669cbd09924c3509ef755690,fc87bebcccab391e11abca867a3b2cea
686673,N06A-Antidepressants (Sales: US$ (purchasing power parity per capita),US$ per capita,,2023-05-04 14:12:48,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,n06a_antidepressants__sales__usd__purchasing_power_parity_per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n06a_antidepressants__sales__usd__purchasing_power_parity_per_capita,,1,,,,,,,,,[],,,,,float,[],bfd1982a952161797e23c1efde899099,0d79942638273f8bbe664d82a96fd8ef
686672,N06A-Antidepressants (Sales: US$ (exchange rate) per capita),US$ per capita,,2023-05-04 14:12:48,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,n06a_antidepressants__sales__usd__exchange_rate__per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n06a_antidepressants__sales__usd__exchange_rate__per_capita,,1,,,,,,,,,[],,,,,float,[],c152a0bcbb537c544f4a85b0af877229,c475b760ad06eabec794e461bfc38cb7
686671,"N06A-Antidepressants (Sales: Million US$, purchasing power parity)",million US$,,2023-05-04 14:12:48,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,n06a_antidepressants__sales__million_usd__purchasing_power_parity,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n06a_antidepressants__sales__million_usd__purchasing_power_parity,,1,,,,,,,,,[],,,,,float,[],02eb4869dce91e313d95674f0d5b0f6f,37ed5c82647eb27bb25eae2fd5ecf024
686670,N06A-Antidepressants (Sales: Million US$ at exchange rate),million US$,,2023-05-04 14:12:48,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,n06a_antidepressants__sales__million_usd_at_exchange_rate,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n06a_antidepressants__sales__million_usd_at_exchange_rate,,1,,,,,,,,,[],,,,,float,[],26b64476914838f672d4c0e0a40f93e9,9bcc8549c1a3cfb5fbbc3ccec54d4685
686669,N06A-Antidepressants (Sales: Million of national currency units),million of national currency units,,2023-05-04 14:12:48,2024-07-08 16:19:12,,,2010-2021,5996,29569,,"{""unit"": ""million of national currency units""}",0,,,n06a_antidepressants__sales__million_of_national_currency_units,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n06a_antidepressants__sales__million_of_national_currency_units,,1,,,,,,,,,[],,,,,float,[],01abc66bb0bc504fa11ce88a6dc221c4,d1a8d4954bbded14ae01281652027a1a
686668,N05C-Hypnotics and sedatives (Sales: % of total sales),%,,2023-05-04 14:12:48,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,n05c_hypnotics_and_sedatives__sales__pct_of_total_sales,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05c_hypnotics_and_sedatives__sales__pct_of_total_sales,,1,,,,,,,,,[],,,,,float,[],ec89d0fec69b55d3d97694697d9e382e,501f25ac6996a0247e1a28a06b3b2e83
686667,N05C-Hypnotics and sedatives (Sales: US$ (purchasing power parity per capita),US$ per capita,,2023-05-04 14:12:48,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,n05c_hypnotics_and_sedatives__sales__usd__purchasing_power_parity_per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05c_hypnotics_and_sedatives__sales__usd__purchasing_power_parity_per_capita,,1,,,,,,,,,[],,,,,float,[],5318ae7ea7d05c31524e6e40128136b7,09ec346d1f8ac1dfef5a953054ed7f0a
686666,N05C-Hypnotics and sedatives (Sales: Million US$ at exchange rate),million US$,,2023-05-04 14:12:48,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,n05c_hypnotics_and_sedatives__sales__million_usd_at_exchange_rate,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05c_hypnotics_and_sedatives__sales__million_usd_at_exchange_rate,,1,,,,,,,,,[],,,,,float,[],404e36315a4bf5b8268f82820160260a,429a8fb40624a08de994ffd87f143296
686665,N05C-Hypnotics and sedatives (Sales: US$ (exchange rate) per capita),US$ per capita,,2023-05-04 14:12:48,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,n05c_hypnotics_and_sedatives__sales__usd__exchange_rate__per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05c_hypnotics_and_sedatives__sales__usd__exchange_rate__per_capita,,1,,,,,,,,,[],,,,,float,[],b409e867b137d1c67e0a2c52fc72dafe,5f8b4f444a9340e90a3309390e6004e7
686664,"N05C-Hypnotics and sedatives (Sales: Million US$, purchasing power parity)",million US$,,2023-05-04 14:12:48,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,n05c_hypnotics_and_sedatives__sales__million_usd__purchasing_power_parity,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05c_hypnotics_and_sedatives__sales__million_usd__purchasing_power_parity,,1,,,,,,,,,[],,,,,float,[],c09a9e074923f4ce4d9ca5096fbfbd53,861dacfbc5332dd411200522afdcb27d
686663,N05C-Hypnotics and sedatives (Sales: Million of national currency units),million of national currency units,,2023-05-04 14:12:48,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""million of national currency units""}",0,,,n05c_hypnotics_and_sedatives__sales__million_of_national_currency_units,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05c_hypnotics_and_sedatives__sales__million_of_national_currency_units,,1,,,,,,,,,[],,,,,float,[],ac945c11872702a3a07d5106a2abcdb9,68b365ea83fb6c7ce58d01976077c317
686662,N05B-Anxiolytics (Sales: % of total sales),%,,2023-05-04 14:12:48,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,n05b_anxiolytics__sales__pct_of_total_sales,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05b_anxiolytics__sales__pct_of_total_sales,,1,,,,,,,,,[],,,,,float,[],65a88ca986cfc4a7a23131eb49dc7fe8,b029e9147ebe0a171f5042263bfd8855
686661,N05B-Anxiolytics (Sales: US$ (purchasing power parity per capita),US$ per capita,,2023-05-04 14:12:47,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,n05b_anxiolytics__sales__usd__purchasing_power_parity_per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05b_anxiolytics__sales__usd__purchasing_power_parity_per_capita,,1,,,,,,,,,[],,,,,float,[],36d7023ed1d55d108ce8fef4b64f9709,aad84f5f9a231fbaab55b2deb6ba15f4
686660,N05B-Anxiolytics (Sales: US$ (exchange rate) per capita),US$ per capita,,2023-05-04 14:12:47,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,n05b_anxiolytics__sales__usd__exchange_rate__per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05b_anxiolytics__sales__usd__exchange_rate__per_capita,,1,,,,,,,,,[],,,,,float,[],f917ffb214196517041bd10c629e6c37,c3489a9cbf5e705cb17a4da67d07fa2e
686659,"N05B-Anxiolytics (Sales: Million US$, purchasing power parity)",million US$,,2023-05-04 14:12:47,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,n05b_anxiolytics__sales__million_usd__purchasing_power_parity,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05b_anxiolytics__sales__million_usd__purchasing_power_parity,,1,,,,,,,,,[],,,,,float,[],046d7f75eee2f9184ebf7e14162ecc06,b3685e28ddc76affb157a9e45142a358
686658,N05B-Anxiolytics (Sales: Million US$ at exchange rate),million US$,,2023-05-04 14:12:47,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,n05b_anxiolytics__sales__million_usd_at_exchange_rate,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05b_anxiolytics__sales__million_usd_at_exchange_rate,,1,,,,,,,,,[],,,,,float,[],f17347bd23434639ce4ea5e1856c3547,c6be0acce3ee2feae957f3034b7b472c
686657,N05B-Anxiolytics (Sales: Million of national currency units),million of national currency units,,2023-05-04 14:12:47,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""million of national currency units""}",0,,,n05b_anxiolytics__sales__million_of_national_currency_units,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05b_anxiolytics__sales__million_of_national_currency_units,,1,,,,,,,,,[],,,,,float,[],8367fbd71f1a8b76c9b808da5cbe5b67,ffa2cc9893c18d6b58c3d331f6458734
686656,N02-Analgesics (Sales: US$ (purchasing power parity per capita),US$ per capita,,2023-05-04 14:12:47,2024-07-08 16:19:11,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,n02_analgesics__sales__usd__purchasing_power_parity_per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n02_analgesics__sales__usd__purchasing_power_parity_per_capita,,1,,,,,,,,,[],,,,,float,[],0f8a3c5abf1e20487440b8cb2198f4d8,73ff6c2ca40853b02ed1e1dbacbb79a7
686655,N02-Analgesics (Sales: US$ (exchange rate) per capita),US$ per capita,,2023-05-04 14:12:47,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,n02_analgesics__sales__usd__exchange_rate__per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n02_analgesics__sales__usd__exchange_rate__per_capita,,1,,,,,,,,,[],,,,,float,[],db0d6fee36e1e75b1b71446f527fef19,f4a51c3edaa18cb2388e1fc0b92ffede
686654,N02-Analgesics (Sales: % of total sales),%,,2023-05-04 14:12:47,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,n02_analgesics__sales__pct_of_total_sales,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n02_analgesics__sales__pct_of_total_sales,,1,,,,,,,,,[],,,,,float,[],ddcc9f8c6716673c783fd5a4982f0125,aa0d951979339d6fbdb35fa288179a91
686653,"N02-Analgesics (Sales: Million US$, purchasing power parity)",million US$,,2023-05-04 14:12:47,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,n02_analgesics__sales__million_usd__purchasing_power_parity,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n02_analgesics__sales__million_usd__purchasing_power_parity,,1,,,,,,,,,[],,,,,float,[],971104662821a0475ba5eee0c6a9336b,372a8f7dd29db7f84c95952785025853
686652,N02-Analgesics (Sales: Million US$ at exchange rate),million US$,,2023-05-04 14:12:47,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,n02_analgesics__sales__million_usd_at_exchange_rate,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n02_analgesics__sales__million_usd_at_exchange_rate,,1,,,,,,,,,[],,,,,float,[],ec94e98b85811105eb0c4a543abfa15b,d83e00a67ee45be66e7638228a40c25a
686651,N02-Analgesics (Sales: Million of national currency units),million of national currency units,,2023-05-04 14:12:47,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""million of national currency units""}",0,,,n02_analgesics__sales__million_of_national_currency_units,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n02_analgesics__sales__million_of_national_currency_units,,1,,,,,,,,,[],,,,,float,[],bf460feba51cd817a06e27a2426ff007,11dee5efa7190e3d9a44cd67670b9c7d
686650,N-Nervous system (Sales: % of total sales),%,,2023-05-04 14:12:47,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,n_nervous_system__sales__pct_of_total_sales,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n_nervous_system__sales__pct_of_total_sales,,1,,,,,,,,,[],,,,,float,[],bd665dc4d104763eceea7b26c94026ce,dcc4a6fab24764c58c87119f2c03c4a5
686649,N-Nervous system (Sales: US$ (purchasing power parity per capita),US$ per capita,,2023-05-04 14:12:47,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,n_nervous_system__sales__usd__purchasing_power_parity_per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n_nervous_system__sales__usd__purchasing_power_parity_per_capita,,1,,,,,,,,,[],,,,,float,[],c037e4ab9c67c4fab815dc610cecbb8c,3883b362fd8190e2a454f40a1d679c54
686648,N-Nervous system (Sales: US$ (exchange rate) per capita),US$ per capita,,2023-05-04 14:12:47,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,n_nervous_system__sales__usd__exchange_rate__per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n_nervous_system__sales__usd__exchange_rate__per_capita,,1,,,,,,,,,[],,,,,float,[],2a98428227da3c616715d90cd54382d5,e231e1def6b3fee49e940feaab9d0e2c
686647,"N-Nervous system (Sales: Million US$, purchasing power parity)",million US$,,2023-05-04 14:12:47,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,n_nervous_system__sales__million_usd__purchasing_power_parity,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n_nervous_system__sales__million_usd__purchasing_power_parity,,1,,,,,,,,,[],,,,,float,[],7ebcdd24666ae15c5aa5ca1c6c8d8f5e,27f8d832eb87ebb139c8d0054c98506a
686646,N-Nervous system (Sales: Million US$ at exchange rate),million US$,,2023-05-04 14:12:47,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,n_nervous_system__sales__million_usd_at_exchange_rate,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n_nervous_system__sales__million_usd_at_exchange_rate,,1,,,,,,,,,[],,,,,float,[],77159d3548fb89f79da1b20ba243f197,d39037568d8de8cd99545db936c16383
686645,N-Nervous system (Sales: Million of national currency units),million of national currency units,,2023-05-04 14:12:47,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""million of national currency units""}",0,,,n_nervous_system__sales__million_of_national_currency_units,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n_nervous_system__sales__million_of_national_currency_units,,1,,,,,,,,,[],,,,,float,[],df7d4667199dfcb132c4b6537bfb0c6c,547cfe101eda6dd9cb3e4cb10f158229
686644,M01A-Antiinflammatory and antirheumatic products non-steroids (Sales: % of total sales),%,,2023-05-04 14:12:47,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__pct_of_total_sales,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__pct_of_total_sales,,1,,,,,,,,,[],,,,,float,[],3a84958cc9b290194f2d0c25e1556e6e,284b6970fd95fd0a57cdc182ab77611c
686643,M01A-Antiinflammatory and antirheumatic products non-steroids (Sales: US$ (purchasing power parity per capita),US$ per capita,,2023-05-04 14:12:47,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__usd__purchasing_power_parity_per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__usd__purchasing_power_parity_per_capita,,1,,,,,,,,,[],,,,,float,[],ede945cbf9837f840cf38828d007c3c1,5531de695db0497475182cfdfde8d650
686642,M01A-Antiinflammatory and antirheumatic products non-steroids (Sales: US$ (exchange rate) per capita),US$ per capita,,2023-05-04 14:12:47,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__usd__exchange_rate__per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__usd__exchange_rate__per_capita,,1,,,,,,,,,[],,,,,float,[],2c19462b846f0eda3782e6c0f087fb94,47865f861821d7c0b1fc35b2028b6a7a
686641,M01A-Antiinflammatory and antirheumatic products non-steroids (Sales: Million US$ at exchange rate),million US$,,2023-05-04 14:12:47,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__million_usd_at_exchange_rate,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__million_usd_at_exchange_rate,,1,,,,,,,,,[],,,,,float,[],4059f3c3c2bc0229a6eeea8d7fca6bbd,a6a3c4cd0d6ff1ce10e818b37d81fbc8
686640,M01A-Antiinflammatory and antirheumatic products non-steroids (Sales: Million of national currency units),million of national currency units,,2023-05-04 14:12:47,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""million of national currency units""}",0,,,m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__million_of_national_currency_units,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__million_of_national_currency_units,,1,,,,,,,,,[],,,,,float,[],725cf43ddd2b3d86106fe523b13193c4,3978b20fddf92303bab12a10ec6f346b
686639,"M01A-Antiinflammatory and antirheumatic products non-steroids (Sales: Million US$, purchasing power parity)",million US$,,2023-05-04 14:12:47,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__million_usd__purchasing_power_parity,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__million_usd__purchasing_power_parity,,1,,,,,,,,,[],,,,,float,[],0f90b820225622d0f58613e8594b9f82,ae7808f5069da3491cd7d4359abf6ec8
686638,M-Musculo-skeletal system (Sales: % of total sales),%,,2023-05-04 14:12:47,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,m_musculo_skeletal_system__sales__pct_of_total_sales,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m_musculo_skeletal_system__sales__pct_of_total_sales,,1,,,,,,,,,[],,,,,float,[],b315b438dc49137a4beef7a69df15731,b79e6d7153d09ff01304c7fdb64640f9
686637,M-Musculo-skeletal system (Sales: US$ (exchange rate) per capita),US$ per capita,,2023-05-04 14:12:47,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,m_musculo_skeletal_system__sales__usd__exchange_rate__per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m_musculo_skeletal_system__sales__usd__exchange_rate__per_capita,,1,,,,,,,,,[],,,,,float,[],5b18574aa4f680c9dea7408c989700c2,61d0449c69e7904df2ffd63c75fed30e
686636,M-Musculo-skeletal system (Sales: US$ (purchasing power parity per capita),US$ per capita,,2023-05-04 14:12:47,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,m_musculo_skeletal_system__sales__usd__purchasing_power_parity_per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m_musculo_skeletal_system__sales__usd__purchasing_power_parity_per_capita,,1,,,,,,,,,[],,,,,float,[],fca741f511370f0d52efc8b7e15af6d7,c3ba0a601b173103112966b6bf3c2d00
686635,"M-Musculo-skeletal system (Sales: Million US$, purchasing power parity)",million US$,,2023-05-04 14:12:47,2024-07-08 16:19:10,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,m_musculo_skeletal_system__sales__million_usd__purchasing_power_parity,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m_musculo_skeletal_system__sales__million_usd__purchasing_power_parity,,1,,,,,,,,,[],,,,,float,[],a67323aea3261c4e5fedad49f82a5417,be1682052625b9a35c8284fc1160af93
686634,M-Musculo-skeletal system (Sales: Million US$ at exchange rate),million US$,,2023-05-04 14:12:47,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,m_musculo_skeletal_system__sales__million_usd_at_exchange_rate,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m_musculo_skeletal_system__sales__million_usd_at_exchange_rate,,1,,,,,,,,,[],,,,,float,[],7c643bc3153257db17e4900952eb2518,e7791093c0bf65b92f61bd531c0b1e32
686633,M-Musculo-skeletal system (Sales: Million of national currency units),million of national currency units,,2023-05-04 14:12:47,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""million of national currency units""}",0,,,m_musculo_skeletal_system__sales__million_of_national_currency_units,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m_musculo_skeletal_system__sales__million_of_national_currency_units,,1,,,,,,,,,[],,,,,float,[],d78afda6b55852b600f424ad1dc684f1,2c33765d658bdbf2d74542279a4c244b
686632,J01-Antibacterials for systemic use (Sales: % of total sales),%,,2023-05-04 14:12:46,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,j01_antibacterials_for_systemic_use__sales__pct_of_total_sales,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j01_antibacterials_for_systemic_use__sales__pct_of_total_sales,,1,,,,,,,,,[],,,,,float,[],fe081624b1c48a23bbc6ef91b0c69166,5711b0cb6cbebd785ec5f9dcecf3bdbc
686631,J01-Antibacterials for systemic use (Sales: US$ (purchasing power parity per capita),US$ per capita,,2023-05-04 14:12:46,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,j01_antibacterials_for_systemic_use__sales__usd__purchasing_power_parity_per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j01_antibacterials_for_systemic_use__sales__usd__purchasing_power_parity_per_capita,,1,,,,,,,,,[],,,,,float,[],41876e9862d2a4d811ada61c28c0559f,4bd21a4a95b38d9bff69305459fcd0fc
686630,J01-Antibacterials for systemic use (Sales: Million of national currency units),million of national currency units,,2023-05-04 14:12:46,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""million of national currency units""}",0,,,j01_antibacterials_for_systemic_use__sales__million_of_national_currency_units,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j01_antibacterials_for_systemic_use__sales__million_of_national_currency_units,,1,,,,,,,,,[],,,,,float,[],a6eff47e0887df3e8403b3733c99f061,3397e374215245adc8d2db5beb2bc8bb
686629,"J01-Antibacterials for systemic use (Sales: Million US$, purchasing power parity)",million US$,,2023-05-04 14:12:46,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,j01_antibacterials_for_systemic_use__sales__million_usd__purchasing_power_parity,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j01_antibacterials_for_systemic_use__sales__million_usd__purchasing_power_parity,,1,,,,,,,,,[],,,,,float,[],1ceac1de7adf0d5eba08fc42f2810799,f0b85ddb89bf4502cc8f0f99cd4ec1f0
686628,J01-Antibacterials for systemic use (Sales: US$ (exchange rate) per capita),US$ per capita,,2023-05-04 14:12:46,2024-07-08 16:19:09,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,j01_antibacterials_for_systemic_use__sales__usd__exchange_rate__per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j01_antibacterials_for_systemic_use__sales__usd__exchange_rate__per_capita,,1,,,,,,,,,[],,,,,float,[],824ce797211e7357547b9e7404f638ad,789de97e7b506430bd0811c05a265574
686627,J01-Antibacterials for systemic use (Sales: Million US$ at exchange rate),million US$,,2023-05-04 14:12:46,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,j01_antibacterials_for_systemic_use__sales__million_usd_at_exchange_rate,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j01_antibacterials_for_systemic_use__sales__million_usd_at_exchange_rate,,1,,,,,,,,,[],,,,,float,[],f03ad3ca6eb36a4cc0685b5f138b73c9,f1956bbe72e7bfa5f6a063865cea6856
686626,J-Antiinfectives for systemic use (Sales: % of total sales),%,,2023-05-04 14:12:46,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,j_antiinfectives_for_systemic_use__sales__pct_of_total_sales,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j_antiinfectives_for_systemic_use__sales__pct_of_total_sales,,1,,,,,,,,,[],,,,,float,[],8854bd90e1b9d1cc85aada62a23ca08d,c41f0b403d2426cbb466f325ae6f5306
686625,J-Antiinfectives for systemic use (Sales: US$ (purchasing power parity per capita),US$ per capita,,2023-05-04 14:12:46,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,j_antiinfectives_for_systemic_use__sales__usd__purchasing_power_parity_per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j_antiinfectives_for_systemic_use__sales__usd__purchasing_power_parity_per_capita,,1,,,,,,,,,[],,,,,float,[],d39c14f0d4390553568b7b03d82e05db,94dce2719c4dd901d9f445187eee0b03
686624,J-Antiinfectives for systemic use (Sales: US$ (exchange rate) per capita),US$ per capita,,2023-05-04 14:12:46,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,j_antiinfectives_for_systemic_use__sales__usd__exchange_rate__per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j_antiinfectives_for_systemic_use__sales__usd__exchange_rate__per_capita,,1,,,,,,,,,[],,,,,float,[],6c4f909a9a9dc8ea41f4973493b7553a,8f96c9c299036e37ce279d3d26f80f24
686623,"J-Antiinfectives for systemic use (Sales: Million US$, purchasing power parity)",million US$,,2023-05-04 14:12:46,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,j_antiinfectives_for_systemic_use__sales__million_usd__purchasing_power_parity,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j_antiinfectives_for_systemic_use__sales__million_usd__purchasing_power_parity,,1,,,,,,,,,[],,,,,float,[],33c2373891851ee000c970e22aac56f2,87081de6f6620da43b410175003cfd7b
686622,J-Antiinfectives for systemic use (Sales: Million US$ at exchange rate),million US$,,2023-05-04 14:12:46,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,j_antiinfectives_for_systemic_use__sales__million_usd_at_exchange_rate,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j_antiinfectives_for_systemic_use__sales__million_usd_at_exchange_rate,,1,,,,,,,,,[],,,,,float,[],f1f857554b42efb36a2adede6eab732a,9ed47fbcd721bc0b300e43e6d651c57e
686621,J-Antiinfectives for systemic use (Sales: Million of national currency units),million of national currency units,,2023-05-04 14:12:46,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""million of national currency units""}",0,,,j_antiinfectives_for_systemic_use__sales__million_of_national_currency_units,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j_antiinfectives_for_systemic_use__sales__million_of_national_currency_units,,1,,,,,,,,,[],,,,,float,[],946afcb9bcaec96b8cead4b325a5af35,f9ada49e83ceb684e1ba1a3d679996f7
686620,"H-Systemic hormonal preparations, excluding sex hormones and insulins (Sales: % of total sales)",%,,2023-05-04 14:12:46,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__pct_of_total_sales,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__pct_of_total_sales,,1,,,,,,,,,[],,,,,float,[],8364f58d0c1bec00d942704813dea276,b412a70e03ec06962b98559e0e27e923
686619,"H-Systemic hormonal preparations, excluding sex hormones and insulins (Sales: US$ (exchange rate) per capita)",US$ per capita,,2023-05-04 14:12:46,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__usd__exchange_rate__per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__usd__exchange_rate__per_capita,,1,,,,,,,,,[],,,,,float,[],d12b90b98a30c3cc36ebac2f1ceed8c6,8b9c2f693ab76f49b23f76eb51daa336
686618,"H-Systemic hormonal preparations, excluding sex hormones and insulins (Sales: US$ (purchasing power parity per capita)",US$ per capita,,2023-05-04 14:12:46,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__usd__purchasing_power_parity_per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__usd__purchasing_power_parity_per_capita,,1,,,,,,,,,[],,,,,float,[],7c5ece29e9821c469b586ca9f321733f,efb4ca731042a31c876e3190d66ba654
686617,"H-Systemic hormonal preparations, excluding sex hormones and insulins (Sales: Million US$, purchasing power parity)",million US$,,2023-05-04 14:12:46,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__million_usd__purchasing_power_parity,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__million_usd__purchasing_power_parity,,1,,,,,,,,,[],,,,,float,[],f17159175f76dd3d99ad1d5e84dc3ec8,af18c3f080b5508f76287e1994d086cb
686616,"H-Systemic hormonal preparations, excluding sex hormones and insulins (Sales: Million US$ at exchange rate)",million US$,,2023-05-04 14:12:46,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__million_usd_at_exchange_rate,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__million_usd_at_exchange_rate,,1,,,,,,,,,[],,,,,float,[],fed99bc2205afe275fd06e6f161a93e1,f4d141ba4cba753ea0a87ca3b1dcdc24
686615,"H-Systemic hormonal preparations, excluding sex hormones and insulins (Sales: Million of national currency units)",million of national currency units,,2023-05-04 14:12:46,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""million of national currency units""}",0,,,h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__million_of_national_currency_units,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__million_of_national_currency_units,,1,,,,,,,,,[],,,,,float,[],73a3f0c4ad1f6f483f677f496c1b64c4,1702f78e30cdfbcccd4fb7a82bb9cf48
686614,G03-Sex hormones and modulators of the genital system (Sales: % of total sales),%,,2023-05-04 14:12:46,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,g03_sex_hormones_and_modulators_of_the_genital_system__sales__pct_of_total_sales,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g03_sex_hormones_and_modulators_of_the_genital_system__sales__pct_of_total_sales,,1,,,,,,,,,[],,,,,float,[],aed7b5779385db91bd16bc66386b1c96,80c6b2b79a2c809ca192e904db599c31
686613,G03-Sex hormones and modulators of the genital system (Sales: US$ (purchasing power parity per capita),US$ per capita,,2023-05-04 14:12:46,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,g03_sex_hormones_and_modulators_of_the_genital_system__sales__usd__purchasing_power_parity_per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g03_sex_hormones_and_modulators_of_the_genital_system__sales__usd__purchasing_power_parity_per_capita,,1,,,,,,,,,[],,,,,float,[],131eb0257d8249bf151cab553e798d3d,d964e20b875c7da187e11cf317d9ea18
686612,G03-Sex hormones and modulators of the genital system (Sales: US$ (exchange rate) per capita),US$ per capita,,2023-05-04 14:12:46,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,g03_sex_hormones_and_modulators_of_the_genital_system__sales__usd__exchange_rate__per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g03_sex_hormones_and_modulators_of_the_genital_system__sales__usd__exchange_rate__per_capita,,1,,,,,,,,,[],,,,,float,[],bb4fbdd060915cc1e3318ea6ccaa7ac7,cd1387ffe0f20cb6222948c21e838479
686611,"G03-Sex hormones and modulators of the genital system (Sales: Million US$, purchasing power parity)",million US$,,2023-05-04 14:12:45,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,g03_sex_hormones_and_modulators_of_the_genital_system__sales__million_usd__purchasing_power_parity,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g03_sex_hormones_and_modulators_of_the_genital_system__sales__million_usd__purchasing_power_parity,,1,,,,,,,,,[],,,,,float,[],60ba6a910905ba7134124eb295021633,103febaa4f1c7632601c4c92eec0df0b
686610,G03-Sex hormones and modulators of the genital system (Sales: Million US$ at exchange rate),million US$,,2023-05-04 14:12:45,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,g03_sex_hormones_and_modulators_of_the_genital_system__sales__million_usd_at_exchange_rate,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g03_sex_hormones_and_modulators_of_the_genital_system__sales__million_usd_at_exchange_rate,,1,,,,,,,,,[],,,,,float,[],725d822c1fc2700146b7e6f63452e18e,1ec85971492acbf4dc1cfce58e5f375a
686609,G03-Sex hormones and modulators of the genital system (Sales: Million of national currency units),million of national currency units,,2023-05-04 14:12:45,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""million of national currency units""}",0,,,g03_sex_hormones_and_modulators_of_the_genital_system__sales__million_of_national_currency_units,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g03_sex_hormones_and_modulators_of_the_genital_system__sales__million_of_national_currency_units,,1,,,,,,,,,[],,,,,float,[],863bcfc7202f8395d76b859947ca3302,2ec67014045c07734d552753b746c575
686608,G-Genito urinary system and sex hormones (Sales: % of total sales),%,,2023-05-04 14:12:45,2024-07-08 16:19:07,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,g_genito_urinary_system_and_sex_hormones__sales__pct_of_total_sales,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g_genito_urinary_system_and_sex_hormones__sales__pct_of_total_sales,,1,,,,,,,,,[],,,,,float,[],2bc7b752bfa1131d2c853a0ba68884fc,50602e935c8392d5974e64283460fe38
686607,G-Genito urinary system and sex hormones (Sales: US$ (purchasing power parity per capita),US$ per capita,,2023-05-04 14:12:45,2024-07-08 16:19:08,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,g_genito_urinary_system_and_sex_hormones__sales__usd__purchasing_power_parity_per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g_genito_urinary_system_and_sex_hormones__sales__usd__purchasing_power_parity_per_capita,,1,,,,,,,,,[],,,,,float,[],aee99ac1f486cd58d5a6c75a59a44e8f,898b6c09cb2549506aed4c04d5e96779
686606,G-Genito urinary system and sex hormones (Sales: US$ (exchange rate) per capita),US$ per capita,,2023-05-04 14:12:45,2024-07-08 16:19:07,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,g_genito_urinary_system_and_sex_hormones__sales__usd__exchange_rate__per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g_genito_urinary_system_and_sex_hormones__sales__usd__exchange_rate__per_capita,,1,,,,,,,,,[],,,,,float,[],68aa58739608ea001f71fe2ed6e20bd7,7e868c4c1f63ff675d452b316eb94383
686605,"G-Genito urinary system and sex hormones (Sales: Million US$, purchasing power parity)",million US$,,2023-05-04 14:12:45,2024-07-08 16:19:07,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,g_genito_urinary_system_and_sex_hormones__sales__million_usd__purchasing_power_parity,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g_genito_urinary_system_and_sex_hormones__sales__million_usd__purchasing_power_parity,,1,,,,,,,,,[],,,,,float,[],b907817416a78c942f11ecd2b0778571,0dac2ae8de05a1d899ee2b0737da9d2d
686604,G-Genito urinary system and sex hormones (Sales: Million US$ at exchange rate),million US$,,2023-05-04 14:12:45,2024-07-08 16:19:07,,,2010-2021,5996,29569,,"{""unit"": ""million US$""}",0,,,g_genito_urinary_system_and_sex_hormones__sales__million_usd_at_exchange_rate,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g_genito_urinary_system_and_sex_hormones__sales__million_usd_at_exchange_rate,,1,,,,,,,,,[],,,,,float,[],b26d599cd86483305d840f56e6816805,1fcd239f4b3e1f6f537b95e8bb46f513
686603,C10-Lipid modifying agents (Sales: US$ (exchange rate) per capita),US$ per capita,,2023-05-04 14:12:45,2024-07-08 16:19:07,,,2010-2021,5996,29569,,"{""unit"": ""US$ per capita""}",0,,,c10_lipid_modifying_agents__sales__usd__exchange_rate__per_capita,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#c10_lipid_modifying_agents__sales__usd__exchange_rate__per_capita,,1,,,,,,,,,[],,,,,float,[],2f0439bc8b2b69ed716bf2c2fe0f2fea,acff4d96c8ea0dd33437477847013f42
686602,C10-Lipid modifying agents (Sales: % of total sales),%,,2023-05-04 14:12:45,2024-07-08 16:19:07,,,2010-2021,5996,29569,,"{""unit"": ""%""}",0,,,c10_lipid_modifying_agents__sales__pct_of_total_sales,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#c10_lipid_modifying_agents__sales__pct_of_total_sales,,1,,,,,,,,,[],,,,,float,[],ac4e33d47a039b59d51253d98aa2d789,27cdb73e055b1a8e21f2a326061a8ac6
686601,G-Genito urinary system and sex hormones (Sales: Million of national currency units),million of national currency units,,2023-05-04 14:12:45,2024-07-08 16:19:07,,,2010-2021,5996,29569,,"{""unit"": ""million of national currency units""}",0,,,g_genito_urinary_system_and_sex_hormones__sales__million_of_national_currency_units,grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g_genito_urinary_system_and_sex_hormones__sales__million_of_national_currency_units,,1,,,,,,,,,[],,,,,float,[],0d10567d084133f4d60d5fe3be5cfa75,5138cf54bb2c8503e829357c6cf89f85